Prevalence study of genetically defined skeletal muscle channelopathies in England.
about
Myotonic disorders: A review articlePhysiological and Pathophysiological Insights of Nav1.4 and Nav1.5 ComparisonGenetic neurological channelopathies: molecular genetics and clinical phenotypes.Channelopathies of skeletal muscle excitabilityPhenotypic variation of Val1589Met mutation in a four-generation Chinese pedigree with mild paramyotonia congenitia: case report.SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathiesRandomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.Imaging alterations in skeletal muscle channelopathies: a study in 15 patientsMice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis.Diagnosis of skeletal muscle channelopathies.Susac's syndrome: clinical course and epidemiology in a Central European population.ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation.Atrial pacing for the management of ventricular arrhythmias in Andersen-Tawil syndrome.Review of the Diagnosis and Treatment of Periodic Paralysis.Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia.Sodium Channelopathies of Skeletal Muscle.Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.
P2860
Q26747746-4E13585E-4EB5-4D30-88BF-2E0EAFD99269Q26772794-070359AF-3D9D-4F1B-809A-995255654622Q26777559-7082C944-2869-48F3-838D-E001583ED6A5Q28082428-629CDDC1-347A-44EF-9510-CFBD1693A704Q35145290-8439917E-C0BB-4B12-BC5B-B885E87CD80CQ36585034-D0DA4EAA-3C1D-4847-86C5-AEEB5EB43FF1Q36796484-8E792EFC-CFD8-44C1-BC31-D3A5900C7FEAQ36876590-E5776022-4726-48E6-8006-C323F3340118Q36967712-FF180754-ADF7-4EF4-928F-3D6BD3A151ECQ38143226-3EFF5FCD-9DE8-4F9A-86C3-1379120E179BQ39242920-E8E8E922-3D9A-4812-8F81-F61DA841B4AAQ40814070-2F791125-76AD-4E10-8721-19D375201081Q42198313-D8F1003A-CA67-4553-A7FF-2E6EEC042DDAQ45957826-602911B7-018E-44C0-844B-293F1BF5F88BQ49375716-C1E6404D-EEBE-4278-8C69-16378BC21015Q49908047-F2869927-9246-45CF-AD5A-8E80344E4A14Q53541761-A1D8C616-1399-42D2-8746-D7A533C9B9D8Q55176457-42E35BF0-DF4B-4B78-BA5F-D252D3DBDB00
P2860
Prevalence study of genetically defined skeletal muscle channelopathies in England.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prevalence study of genetically defined skeletal muscle channelopathies in England.
@en
type
label
Prevalence study of genetically defined skeletal muscle channelopathies in England.
@en
prefLabel
Prevalence study of genetically defined skeletal muscle channelopathies in England.
@en
P2093
P2860
P1433
P1476
Prevalence study of genetically defined skeletal muscle channelopathies in England.
@en
P2093
Alejandro Horga
Andrea Haworth
Dipa L Raja Rayan
Doreen Fialho
Emma Matthews
James A Burge
Mary B Davis
Michael G Hanna
Simona Portaro
P2860
P304
P356
10.1212/WNL.0B013E31828CF8D0
P407
P577
2013-03-20T00:00:00Z